Waters to buy Becton unit in a $17.5 billion deal
Digest more
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences innovation leader.
Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge insurers by increasing costs and restricting Medicaid coverage. Waters Corp is expanding through a significant acquisition,
StockStory.org on MSN1d
Why Waters Corporation (WAT) Stock Is Down TodayShares of scientific instruments company Waters Corporation (NYSE:WAT) fell 12.8% in the morning session after the company announced a definitive agreement to merge with the Biosciences & Diagnostic Solutions business of Becton,